Cargando...
Diagnostic performance of (18)F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
PURPOSE: The introduction of ligands targeting prostate-specific membrane antigen (PSMA), especially (68)Ga-PSMA-11, has changed the management of patients with prostate cancer (PCa). (18)F-Labelled ligands can be produced in larger amounts and therefore can improve availability for a larger group o...
Guardado en:
| Publicado en: | Eur J Nucl Med Mol Imaging |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer Berlin Heidelberg
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6182394/ https://ncbi.nlm.nih.gov/pubmed/30027419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4089-x |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|